Franklin Resources
KURA icon

Franklin Resources’s Kura Oncology KURA Stock Holding History

Franklin Resources’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Buy
21,351
+6,998
+49% +$66K ﹤0.01% 2797
2026
Q1 		$117K Sell
14,353
-266,762
-95% -$2.29M ﹤0.01% 2897
2025
Q4 		$2.92M Buy
281,115
+52,671
+23% +$553K ﹤0.01% 1638
2025
Q3 		$2.02M Sell
228,444
-73,970
-24% -$527K ﹤0.01% 1770
2025
Q2 		$1.74M Sell
302,414
-1,262,452
-81% -$7.73M ﹤0.01% 1763
2025
Q1 		$10.3M Buy
1,564,866
+26,274
+2% +$205K ﹤0.01% 1089
2024
Q4 		$13.4M Sell
1,538,592
-49,809
-3% -$717K ﹤0.01% 1031
2024
Q3 		$28.7M Buy
1,588,401
+23,113
+1% +$468K 0.01% 774
2024
Q2 		$32.2M Sell
1,565,288
-9,958
-0.6% -$205K 0.01% 700
2024
Q1 		$33.6M Buy
1,575,246
+221,581
+16% +$4.31M 0.01% 705
2023
Q4 		$19.5M Buy
1,353,665
+130,710
+11% +$1.29M 0.01% 760
2023
Q3 		$11.2M Sell
1,222,955
-1,542
-0.1% -$15.7K 0.01% 891
2023
Q2 		$13M Buy
1,224,497
+32,821
+3% +$388K 0.01% 870
2023
Q1 		$14.6M Buy
1,191,676
+126,416
+12% +$1.58M 0.01% 855
2022
Q4 		$13.2M Buy
1,065,260
+430,595
+68% +$6.26M 0.01% 884
2022
Q3 		$8.67M Buy
634,665
+7,542
+1% +$116K ﹤0.01% 965
2022
Q2 		$11.5M Buy
627,123
+1,229
+0.2% +$17.7K 0.01% 920
2022
Q1 		$10.1M Sell
625,894
-349,028
-36% -$5.04M ﹤0.01% 1007
2021
Q4 		$13.6M Sell
974,922
-3,533
-0.4% -$57.2K ﹤0.01% 979
2021
Q3 		$18.3M Sell
978,455
-2,423
-0.2% -$45.7K 0.01% 911
2021
Q2 		$20.5M Buy
980,878
+239,114
+32% +$5.94M 0.01% 852
2021
Q1 		$21M Buy
741,764
+240,144
+48% +$7.6M 0.01% 829
2020
Q4 		$16.4M Buy
+501,620
New +$17.6M 0.01% 858
2016
Q2 		– Sell
-730,500
Closed -$2.96M – 1525
2016
Q1 		$2.96M Sell
730,500
-239,671
-25% -$1.14M ﹤0.01% 1196
2015
Q4 		$8.15M Buy
+970,171
New +$7.64M ﹤0.01% 1044

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Franklin Resources's KURA Position: Q2 2026 in Review

Franklin Resources increased its Kura Oncology (KURA) stake by 49% in Q2 2026, buying an estimated $66K and bringing the position to 21,351 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #2797.

Franklin Resources first reported a position in KURA in Q4 2015 and has held it in 25 quarters since. The position peaked at $33.6M in Q1 2024. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Franklin Resources held 21,351 shares of Kura Oncology worth $234K as of Q2 2026.
  • Franklin Resources bought 6,998 Kura Oncology shares in Q2 2026, an estimated $66K.
  • Kura Oncology made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2797 holding.
  • Franklin Resources first reported a position in Kura Oncology in Q4 2015 and has held it in 25 quarters since.
  • Franklin Resources's Kura Oncology position peaked at $33.6M in Q1 2024.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.